286 related articles for article (PubMed ID: 34155349)
21. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
22. Effective growth-suppressive activity of maternal embryonic leucine-zipper kinase (MELK) inhibitor against small cell lung cancer.
Inoue H; Kato T; Olugbile S; Tamura K; Chung S; Miyamoto T; Matsuo Y; Salgia R; Nakamura Y; Park JH
Oncotarget; 2016 Mar; 7(12):13621-33. PubMed ID: 26871945
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage.
Hui MK; Chan KW; Luk JM; Lee NP; Chung Y; Cheung LC; Srivastava G; Tsao SW; Tang JC; Law S
World J Surg; 2012 Jan; 36(1):90-7. PubMed ID: 21976009
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma.
Gu C; Jing X; Holman C; Sompallae R; Zhan F; Tricot G; Yang Y; Janz S
BMC Cancer; 2018 Nov; 18(1):1152. PubMed ID: 30463534
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
[TBL] [Abstract][Full Text] [Related]
26. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
Wang W; Guo Z; Yu H; Fan L
J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
[TBL] [Abstract][Full Text] [Related]
27. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer.
Zhao H; Wei H; He J; Wang D; Li W; Wang Y; Ai Y; Yang J
Cell Cycle; 2020 Oct; 19(19):2538-2552. PubMed ID: 32857667
[TBL] [Abstract][Full Text] [Related]
28. Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer.
Wang RT; Miao RC; Zhang X; Yang GH; Mu YP; Zhang ZY; Qu K; Liu C
World J Gastroenterol; 2021 Feb; 27(8):692-707. PubMed ID: 33716448
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma.
Liu L; Wu J; Guo Y; Xie W; Chen B; Zhang Y; Li S; Hua Y; Peng B; Shen S
Aging (Albany NY); 2018 Dec; 10(12):4120-4140. PubMed ID: 30580327
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.
Wu HY; Luo LF; Wei F; Jiang HM
World J Surg Oncol; 2023 Nov; 21(1):366. PubMed ID: 38001498
[TBL] [Abstract][Full Text] [Related]
31. MED28 and forkhead box M1 (FOXM1) mediate matrix metalloproteinase 2 (MMP2)-dependent cellular migration in human nonsmall cell lung cancer (NSCLC) cells.
Hsieh NT; Huang CY; Li CC; Wang IC; Lee MF
J Cell Physiol; 2019 Jul; 234(7):11265-11275. PubMed ID: 30499104
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
33. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.
Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z
J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA‑320a suppresses tumour cell proliferation and invasion of renal cancer cells by targeting FoxM1.
Zhao S; Wang Y; Lou Y; Wang Y; Sun J; Luo M; Li W; Miao L
Oncol Rep; 2018 Oct; 40(4):1917-1926. PubMed ID: 30066895
[TBL] [Abstract][Full Text] [Related]
35. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Chen YH; Liu DM; Sha JJ; Xuan HQ; Bo JJ; Huang YR
Med Oncol; 2013 Mar; 30(1):346. PubMed ID: 23263830
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line.
Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255
[TBL] [Abstract][Full Text] [Related]
38. Metadherin/Astrocyte elevated gene-1 positively regulates the stability and function of forkhead box M1 during tumorigenesis.
Yang L; He K; Yan S; Yang Y; Gao X; Zhang M; Xia Z; Huang Z; Huang S; Zhang N
Neuro Oncol; 2017 Mar; 19(3):352-363. PubMed ID: 27923917
[TBL] [Abstract][Full Text] [Related]
39. Correlated low IGF2BP1 and FOXM1 expression predicts a good prognosis in lung adenocarcinoma.
Huang H; Wang D; Guo W; Zhuang X; He Y
Pathol Res Pract; 2019 Jul; 215(7):152433. PubMed ID: 31085008
[TBL] [Abstract][Full Text] [Related]
40. FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target.
Kuda M; Kohashi K; Yamada Y; Maekawa A; Kinoshita Y; Nakatsura T; Iwamoto Y; Taguchi T; Oda Y
Tumour Biol; 2016 Apr; 37(4):5213-23. PubMed ID: 26553361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
